• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification.根据慢性阻塞性肺疾病全球倡议(GOLD)2011分级分类对慢性阻塞性肺疾病(COPD)患者的血清C反应蛋白水平进行分层。
Pak J Med Sci. 2016 Nov-Dec;32(6):1453-1458. doi: 10.12669/pjms.326.10905.
2
The Correlation of Sit-to-Stand Tests with COPD Assessment Test and GOLD Staging Classification.坐姿到站起测试与 COPD 评估测试和 GOLD 分期分类的相关性。
COPD. 2020 Dec;17(6):655-661. doi: 10.1080/15412555.2020.1825661. Epub 2020 Oct 6.
3
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.稳定期慢性阻塞性肺疾病患者的C反应蛋白水平及临床重要预测结果
Eur Respir J. 2006 May;27(5):902-7. doi: 10.1183/09031936.06.00109605. Epub 2006 Feb 2.
4
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.应用 2017 年新版全球慢性阻塞性肺疾病倡议分类标准预测慢性阻塞性肺疾病患者的死亡率:一项队列研究。
Lancet Respir Med. 2018 Mar;6(3):204-212. doi: 10.1016/S2213-2600(18)30002-X. Epub 2018 Jan 10.
5
COPD assessment test score and serum C-reactive protein levels in stable COPD patients.稳定期慢性阻塞性肺疾病(COPD)患者的COPD评估测试分数与血清C反应蛋白水平
Int J Chron Obstruct Pulmon Dis. 2016 Dec 8;11:3137-3143. doi: 10.2147/COPD.S118153. eCollection 2016.
6
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的炎症生物标志物与加重。
JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.
7
CORRELATION OF C-REACTIVE PROTEIN AND COPD SEVERITY.C反应蛋白与慢性阻塞性肺疾病严重程度的相关性
Acta Clin Croat. 2016 Mar;55(1):41-8.
8
The impact of heart failure on the classification of COPD severity.心力衰竭对 COPD 严重程度分类的影响。
J Card Fail. 2012 Aug;18(8):637-44. doi: 10.1016/j.cardfail.2012.05.008. Epub 2012 Jul 13.
9
[Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].慢性阻塞性肺疾病患者C反应蛋白和白细胞介素-18水平、生活质量与肺功能的相关性
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1090-6. doi: 10.3969/j.issn.1672-7347.2011.11.010.
10
Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?慢性阻塞性肺疾病评估测试(CAT)在显示慢性阻塞性肺疾病中的全身炎症及其他成分方面是否有效?
Rev Port Pneumol (2006). 2016 Jan-Feb;22(1):11-7. doi: 10.1016/j.rppnen.2015.08.007. Epub 2015 Oct 31.

引用本文的文献

1
Utility of chronic obstructive pulmonary disease assessment test in perioperative assessment of patients with mild to moderate chronic obstructive pulmonary disease.慢性阻塞性肺疾病评估测试在轻至中度慢性阻塞性肺疾病患者围手术期评估中的应用
J Thorac Dis. 2024 Oct 31;16(10):6595-6603. doi: 10.21037/jtd-24-138. Epub 2024 Oct 17.
2
Relationship between chronic obstructive pulmonary disease and adiponectin concentrations: An updated meta-analysis and single-cell RNA sequencing.慢性阻塞性肺疾病与脂联素浓度的关系:一项更新的荟萃分析和单细胞 RNA 测序研究。
Medicine (Baltimore). 2023 Aug 18;102(33):e34825. doi: 10.1097/MD.0000000000034825.
3
Association between serum adiponectin concentrations and chronic obstructive pulmonary disease: a meta-analysis.血清脂联素浓度与慢性阻塞性肺疾病的关系:一项荟萃分析。
Biosci Rep. 2020 Mar 27;40(3). doi: 10.1042/BSR20192234.
4
The association of serum neuron-specific enolase with other disease markers in chronic obstructive pulmonary disease: A case-control study.慢性阻塞性肺疾病中血清神经元特异性烯醇化酶与其他疾病标志物的关联:一项病例对照研究。
Pak J Med Sci. 2018 Sep-Oct;34(5):1172-1176. doi: 10.12669/pjms.345.15145.
5
Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D.布地奈德/福莫特罗长期治疗可降低D组慢性阻塞性肺疾病患者的循环CRP水平。
PLoS One. 2017 Aug 23;12(8):e0183300. doi: 10.1371/journal.pone.0183300. eCollection 2017.

本文引用的文献

1
Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease.血清淀粉样蛋白 P 成分 3 作为慢性阻塞性肺疾病炎症的新型生物标志物。
Inflammation. 2015 Feb;38(1):89-93. doi: 10.1007/s10753-014-0010-3.
2
Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD.在美国 COPD 队列中,每日步数与血浆 C 反应蛋白和 IL-6 相关。
Chest. 2014 Mar 1;145(3):542-550. doi: 10.1378/chest.13-1052.
3
Systemic inflammation, depression and obstructive pulmonary function: a population-based study.系统炎症、抑郁与阻塞性肺功能:基于人群的研究。
Respir Res. 2013 May 15;14(1):53. doi: 10.1186/1465-9921-14-53.
4
Association between C-reactive protein concentration and chronic obstructive pulmonary disease: a systematic review and meta-analysis.C反应蛋白浓度与慢性阻塞性肺疾病之间的关联:一项系统评价和荟萃分析。
J Int Med Res. 2012;40(5):1629-35. doi: 10.1177/030006051204000501.
5
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的炎症生物标志物和合并症。
Am J Respir Crit Care Med. 2012 Nov 15;186(10):982-8. doi: 10.1164/rccm.201206-1113OC. Epub 2012 Sep 13.
6
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.持续性全身炎症与 COPD 的不良临床结局相关:一种新的表型。
PLoS One. 2012;7(5):e37483. doi: 10.1371/journal.pone.0037483. Epub 2012 May 18.
7
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ).评估 COPD 患者的健康状况。COPD 评估测试(CAT)和临床 COPD 问卷(CCQ)的头对头比较。
BMC Pulm Med. 2012 May 20;12:20. doi: 10.1186/1471-2466-12-20.
8
Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients.常规临床实践中的健康状况评估:门诊患者的慢性阻塞性肺疾病评估测试评分。
Respiration. 2012;84(3):193-9. doi: 10.1159/000336549. Epub 2012 Mar 22.
9
Relation between physical capacity, nutritional status and systemic inflammation in COPD.慢性阻塞性肺疾病(COPD)患者的身体功能、营养状况与全身炎症之间的关系
Clin Respir J. 2011 Jul;5(3):136-42. doi: 10.1111/j.1752-699X.2010.00208.x. Epub 2010 Jun 7.
10
Properties of the COPD assessment test in a cross-sectional European study.COPD 评估测试在一项欧洲横断面研究中的特性。
Eur Respir J. 2011 Jul;38(1):29-35. doi: 10.1183/09031936.00177210. Epub 2011 May 12.

根据慢性阻塞性肺疾病全球倡议(GOLD)2011分级分类对慢性阻塞性肺疾病(COPD)患者的血清C反应蛋白水平进行分层。

Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification.

作者信息

Lin Yi-Hua, Wang Wan-Yu, Hu Su-Xian, Shi Yong-Hong

机构信息

Yi-Hua Lin, MD, Department of Respiratory Medicine, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.

Wan-Yu Wang, MM, Department of Respiratory Medicine, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.

出版信息

Pak J Med Sci. 2016 Nov-Dec;32(6):1453-1458. doi: 10.12669/pjms.326.10905.

DOI:10.12669/pjms.326.10905
PMID:28083044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5216300/
Abstract

BACKGROUND AND OBJECTIVE

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 grading classification has been used to evaluate the severity of patients with chronic obstructive pulmonary disease (COPD). However, little is known about the relationship between the systemic inflammation and this classification. We aimed to study the relationship between serum CRP and the components of the GOLD 2011 grading classification.

METHODS

C-reactive protein (CRP) levels were measured in 391 clinically stable COPD patients and in 50 controls from June 2, 2015 to October 31, 2015 in the First Affiliated Hospital of Xiamen University. The association between CRP levels and the components of the GOLD 2011 grading classification were assessed.

RESULTS

Correlation was found with the following variables: GOLD 2011 group (0.240), age (0.227), pack year (0.136), forced expiratory volume in one second % predicted (FEV%; -0.267), forced vital capacity % predicted (-0.210), number of acute exacerbations in the past year (0.265), number of hospitalized exacerbations in the past year (0.165), British medical Research Council dyspnoea scale (0.121), COPD assessment test score (CAT, 0.233). Using multivariate analysis, FEV% and CAT score manifested the strongest negative association with CRP levels.

CONCLUSIONS

CRP levels differ in COPD patients among groups A-D based on GOLD 2011 grading classification. CRP levels are associated with several important clinical variables, of which FEV% and CAT score manifested the strongest negative correlation.

摘要

背景与目的

慢性阻塞性肺疾病全球倡议组织(GOLD)2011分级分类法已用于评估慢性阻塞性肺疾病(COPD)患者的严重程度。然而,关于全身炎症与该分类法之间的关系却知之甚少。我们旨在研究血清C反应蛋白(CRP)与GOLD 2011分级分类法各组成部分之间的关系。

方法

2015年6月2日至2015年10月31日期间,在厦门大学附属第一医院对391例临床稳定的COPD患者和50例对照者进行了C反应蛋白(CRP)水平检测。评估了CRP水平与GOLD 2011分级分类法各组成部分之间的关联。

结果

发现CRP水平与以下变量存在相关性:GOLD 2011分组(0.240)、年龄(0.227)、吸烟包年数(0.136)、一秒用力呼气容积占预计值百分比(FEV₁%;-0.267)、用力肺活量占预计值百分比(-0.210)、过去一年急性加重次数(0.265)、过去一年住院加重次数(0.165)、英国医学研究委员会呼吸困难量表(0.121)、慢性阻塞性肺疾病评估测试分数(CAT,0.233)。采用多变量分析,FEV₁%和CAT分数与CRP水平的负相关性最强。

结论

根据GOLD 2011分级分类法,A - D组COPD患者的CRP水平存在差异。CRP水平与多个重要临床变量相关,其中FEV₁%和CAT分数的负相关性最强。